Liver Fibrosis in the Post-HCV Era

Area of Science:

• Hepatology
• Virology
• Gastroenterology

Background:

• Interferon-free regimens offer high efficacy and safety for chronic hepatitis C virus (HCV) infection.
• Patients with cirrhosis are a key subgroup for new anti-HCV therapies due to treatment guidelines.

Purpose of the Study:

• To examine the impact of sustained viral response (SVR) on liver fibrosis and cirrhosis progression after HCV treatment.
• To evaluate the clinical outcomes of viral eradication in advanced liver disease stages.

Main Methods:

• Review of current literature on interferon-free HCV treatments.
• Analysis of outcomes related to sustained viral response in patients with cirrhosis.
• Discussion of diagnostic challenges in assessing fibrosis regression and cirrhosis reversal.

Main Results:

• Interferon-free regimens achieve high SVR rates, including in difficult-to-treat populations like cirrhotic patients.
• SVR is associated with potential regression of liver fibrosis and possible reversal of cirrhosis.
• Clinical consequences of viral eradication in advanced disease are significant.

Conclusions:

• Sustained viral response following modern HCV therapy holds promise for improving outcomes in cirrhotic patients.
• Monitoring and assessing fibrosis regression and cirrhosis reversal post-SVR will be a critical clinical and diagnostic focus.